Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Consumer wellness company (subsidiary of Zydus Lifesciences) owning brands including Sugar Free (sweeteners), Complan (health food drink), Glucon-D (glucose powder), Nycil (prickly-heat powder), Everyuth (skincare) and Nutralite (table spreads), largely acquired via the Heinz India portfolio purchase in 2019. Revenue is driven by summer-seasonal brands (Glucon-D, Nycil), health-and-wellness positioning of Sugar Free, and distribution expansion including international markets.
A niche FMCG player holding category-leading positions in artificial sweeteners and glucose powders in India.
Zydus Wellness Ltd. is a constituent of NIFTY 500, NIFTY SMALLCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Zydus Wellness Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
Per-share figures are not restated. Shares outstanding changed from 6.36 crore to 31.80 crore in FY26, consistent with a bonus issue or stock split. Each year's EPS and book value below are as that year was filed, on that year's share count — so the per-share line falls across FY26 even where profit did not. Compare the absolute figures (EBITDA, free cash flow, total debt) and the margins across that boundary, not the per-share ones.
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 6.20 | 54.52 | 41.94 |
| Book value / share (₹) | 183.21 | 891.76 | 842.37 |
| Return on equity | 3.4% | 6.1% | 5.0% |
| Return on capital employed | 3.8% | 6.2% | 5.3% |
| Operating margin | 9.2% | 13.0% | 12.2% |
| Net margin | 5.0% | 12.8% | 11.5% |
| EBITDA | ₹510 Cr | ₹380 Cr | ₹308 Cr |
| Free cash flow | ₹125 Cr | ₹314 Cr | ₹218 Cr |
| Total debt | ₹3,186 Cr | ₹185 Cr | ₹324 Cr |
| Debt to equity | 0.55 | 0.03 | 0.06 |
| Interest coverage | 3.7 | 29.3 | 11.8 |
| Current ratio | 1.88 | 1.48 | 1.58 |
| Shares outstanding | 31,80,00,000 | 6,36,00,000 | 6,36,00,000 |
Open the full income statement, balance sheet and cash flow for ZYDUSWELL →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.